What Stops Some Families From Using Diabetes Technology—and What Helps
A new study identifies barriers and advantages in diabetes device adoption among underrepresented families, revealing that discrimination and burden matter as much as access.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Continuous glucose monitors and insulin pumps improve blood sugar control and quality of life, but not all families who could benefit use them
- Parental age, education level, and language spoken at home are linked to whether families adopt diabetes technology
- Youth who experience discrimination are less likely to use CGMs and pumps, suggesting that social experiences shape device adoption
- Perceived burden of using CGMs—the day-to-day challenges of wearing and managing them—differs between families who use the technology and those who don't
- How families feel about technology itself plays a role in whether they adopt it
Why This Study Matters
Continuous glucose monitors (CGMs) and insulin pumps are proven tools that help people with type 1 diabetes manage their blood sugar and live fuller lives. Yet many families don't use them, even when they're available. Researchers wanted to understand why—especially in communities that have historically been underrepresented in diabetes research and care.
A team analyzed data from 84 families living with type 1 diabetes to identify what factors predict whether youth use both a CGM and an insulin pump. The findings reveal that the story is more complex than access alone.
Family Circumstances and Technology Use
The study found that certain family characteristics were associated with higher technology use. Parents who were older, more educated, and whose youth had lived with diabetes longer were more likely to use both devices. Families where the primary caregiver was not White and did not speak English at home were also more likely to use both technologies—a finding that contradicts stereotypes about disparities and technology adoption.
These patterns suggest that structural factors—like how long a family has navigated diabetes management and their access to education—shape their ability or willingness to adopt new tools.
The Hidden Weight of Discrimination and Burden
Beyond family background, the research pointed to two powerful experiential factors: discrimination and perceived burden.
Youth in families that were not using both technologies reported higher levels of discrimination. On a scale measuring this experience, underutilizers reported a score of 4.23 compared to utilizers' score of 2.49. The researchers found that higher discrimination scores were associated with lower technology use—suggesting that experiences of bias and stigma may discourage families from adopting devices.
Families who weren't using both technologies also reported greater burden from CGM use. They felt the day-to-day challenges of wearing and maintaining the device more acutely than families who were using it. Yet among utilizers, acceptance of the technology itself was higher, indicating that how families view the technology matters.
What This Means
This research highlights that technology adoption isn't just about whether a device exists or whether a family can afford it. Discrimination, the perceived burden of device management, and overall acceptance all play a role.
For healthcare providers and communities supporting families with type 1 diabetes, the findings suggest the importance of addressing not only access but also the social and emotional experiences that shape whether families feel comfortable and supported in using available tools.
Evidence label
Source: Diabetes technology & therapeutics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DWhat We're Learning About Diabetic Ketoacidosis in Type 1 Diabetes: A French StudyPubMed indexed literature
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature